1Olson JE,Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results analysis. Cancer,2002,95 : 1504.
2Diamond C, Taylor TH, Aboumrad T, et al. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment and survival. Cancer, 2006,106 : 128.
3Basso U, Brandes AA. Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma. Eur J Cancer,2002,38: 1298.
4Shenkier TN, Blay JY, O'Neill BP, et al. Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaboration group. J Clin Oncol,2005,23: 2233.
5Gerstner E, Batchelor T. Primary CNS lymphoma. Expert Rev Anticancer Ther. 2007,7 : 689.
6Ferreri A J, Abrey LE, Blay J Y, et al. Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland,June 12 to 15,2002. J Clin Oncol,2003,21:2407.
7Shibamoto Y, Ogino H, Hasegawa M, et al. Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s. Int J Radiat Oncol Biol Phys,2005,62 : 809.
8Shibamoto Y, Hayabuchi N, Hiratsuka J, et al. Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation. Caneer, 2003,97: 128.
9DeAngelis LM, Seiferheld W, Schold SC, et al. Combination chemotherapy and radiotherapy for primary central nervous lymphoma: Radiation Therapy Oneology Group Study 93-10. J Clin Oncol, 2002,20 : 4643.
10Omuro AM,DeAngelis LM,Yahalom J,et al. Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete followed-up. Neurology, 2005,64 : 69.
5Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end Resutls analysis [ J ]. Cancer, 2002,95 (7) :1504-1510.
6Olson J E, Janney C A, Rao R D, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis [J]. Cancer, 2002,95(7): 1504-1510.
7Olson JE,Janney CA,Rao RD.et al.The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma:A Surveillance,Epidemiology,and End Results a-nalysis.Cancer,2002,95:1504.
8Bhagavathi S,Wilson JD.Primary central nervous system lymphoma.Arch Pathol Lab Med,2008,132:1830.
9Montesinos-Rongen M,Siebert R,Deckert M.Primary lymphoma of the central nervous system; just DLBCL or not? Blood,2009,113:7.
10Alecio-Mattei T,Aléio-Mattei J,Aguiar PH,et al.Primary central nervous system lymphomas in immunocompetent patients.Neurocirugia,2006,17:46.
